PDI extends sales service agreement with top-10 pharma company

Share this article:

PDI, Inc. announced that it has extended its sales services agreement with a top-10 pharma company through April 2009 to promote its anti-viral medication on a seasonal basis. This initiative is expected to generate approximately $10.5M during the 2007-2008 season, PDI said.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.